| 05th week of 2011 patent applcation highlights part 52 |
| Patent application number | Title | Published |
|---|
| 20110028716 | Dye for a Dye-Sensitised Solar Cell, and a Solar Cell Comprising the Same - The present invention relates to a dye for a dye-sensitised solar cell. The dye according to the present invention has a high degree of light absorbency and can improve the photoelectric current conversion efficiency when employed in a light-absorbing layer for a solar cell. | 2011-02-03 |
| 20110028717 | AZAINDOLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONISTIC ACTIVITY - The present invention creates an azaindole derivative having DP receptor antagonistic activity and a pharmaceutical composition comprising the said compound as an active ingredient, and further providing a therapeutic agent for treating allergic diseases. | 2011-02-03 |
| 20110028718 | PARACYCLOPHANE-BASED LIGANDS, THEIR PREPARATION AND USE IN CATALYSIS - A substituted paracyclophane is described of formula (I) wherein X | 2011-02-03 |
| 20110028719 | SCREENING METHODS FOR AMYLOID BETA MODULATORS - The present invention relates to methods for screening, identifying, and/or quantifying modulators of amyloid and/or aggregates, fibrils or components thereof, in particular modulators of amyloid β-peptide (Aβ) or Aβ fibrils. Aspects of the invention provide methods for screening putative modulators against an Amyloid target, in particular an Aβ target, so as to determine which modulators bind to or interact with the target, or interfere with the interaction of an indicator agent and the target. Particular aspects of the invention employ mass spectrometric methods for the screening of an Amyloid target against compound libraries, in particular mixtures of compounds or combinatorial libraries. | 2011-02-03 |
| 20110028720 | New Coupling Agents for Peptide Synthesis - The present invention is directed to compounds of the formula: | 2011-02-03 |
| 20110028721 | Chromophore and Polymer Capable of Detecting the Presence of Various Neurotoxins and Method of Use - Applicants have produced a chromophore and a polymer that are highly sensitive to the presence of various agents, including organophosphates, pesticides, neurotoxins, metal ions, some explosives, and biological toxins. The detection is accomplished by detecting a change in the fluorescence characteristics of the chromophore or polymer when in the presence of the agent to be detected. The chromophore and polymer may be incorporated into sensors of various types, and they are adaptable for potential field use in areas where detection of these types of agents is desired. | 2011-02-03 |
| 20110028722 | NOVEL SOLVATE AND CRYSTALLINE FORMS OF CARBAMOYL-CYCLOHEXANE DERIVATIVES - The present invention relates to novel solvate and crystalline forms of carbamoyl-cyclohexane derivatives and, more particularly, to novel solvate and crystalline forms of trans-1{4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea hydrochloride. Processes for the preparation of these forms, compositions containing these forms, and methods of use thereof are also described. | 2011-02-03 |
| 20110028723 | Tridentate Platinum (II) Complexes - A platinum (II) complex of the general formula (I) or (II), in which Ar1, Ar2, and Ar3 are each independently aryl, heteroaryl, or heterocyclic. Ar1, Ar2, and Ar3 together form a tridentate ligand coordinated to the platinum through atoms X, Y, and Z, respectively, and X, Y, and Z are independently carbon or nitrogen. V is a bridging group or a covalent bond, and W is an anion. In general formula (I) in some cases, Ar1 is an anion and Ar2 and Ar3 are neutral; in other cases, Ar1 and Ar3 are neutral and Ar2 is an anion. In general formula (II), in some cases, Ar3 is an anion and Ar1 and Ar2 are neutral; in other cases, Ar1 and Ar3 are neutral and Ar2 is an anion. The complexes are asymmetric. The complexes emit in the UV to near IR range and are useful as emitters for organic light emitting devices. | 2011-02-03 |
| 20110028724 | POLYMERS OF NAPTHALENE TETRACARBOXYLIC DIIMIDE DIMERS - Polymers of naphthalene tetracarboxylic diimide dimmers are provided. The polymers are of the Formula I | 2011-02-03 |
| 20110028725 | Preparation and Use of Alkylating Agents - The present disclosure provides methods of synthesizing alkylating agents and methods of use. | 2011-02-03 |
| 20110028726 | METHOD FOR PREPARING ARGATROBAN MONOHYDRATE AND A PROCESS FOR ITS SYNTHESIS - A method is described for preparing argatroban monohydrate obtained from (2R,4R)-1-[N | 2011-02-03 |
| 20110028727 | PROCESS FOR THE SELECTIVE PREPARATION OF 3-METHYLPYRIDINE (3-PICOLINE) FROM ACROLEIN AND ONE OR MORE AMMONIUM SALTS DISSOLVED IN WATER - The present invention relates to a process for the selective preparation of 3-methylpyridine, characterized in that acrolein and one or more ammonium salt(s) dissolved in water are reacted continuously under high pressures and at temperatures of 200-400° C. | 2011-02-03 |
| 20110028728 | PROCESS FOR THE PREPARATION OF CRYSTALLINE DEXLANSOPRAZOLE - Process for the preparation of crystalline anhydrous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroetoxy)-2-piridyl]methyl]sulphinyl]benzimidazole (dexlansoprazole). | 2011-02-03 |
| 20110028729 | Process for preparing aryl-substituted pyrazoles - The present invention relates to a process for preparing 1-aryl-substituted pyrazoles, comprising the reaction of alkoxy enones and enamino ketones with arylhydrazine derivatives to give 1-aryl-substituted dihydro-1H-pyrazoles, the further reaction thereof with elimination of water to give 1-aryl-substituted trihalomethylpyrazoles, and the further processing thereof. | 2011-02-03 |
| 20110028730 | CYCLIC COMPOUNDS AND THE USE THEREOF AS LIGHT ABSORBERS, LIGHT EMITTERS, OR COMPLEX LIGANDS - The use of cyclic compounds of the formula (I) | 2011-02-03 |
| 20110028731 | PROCESS FOR THE MANUFACTURE OF NITROPROPANES - Provided is a process for the formation of 2-nitropropane and/or 2,2-dinitropropane by the nitration of propane with dilute nitric acid. | 2011-02-03 |
| 20110028732 | NITRATED HYDROCARBONS, DERIVATIVES, AND PROCESSES FOR THEIR MANUFACTURE - Provided is a process for the formation of nitrated compounds by the nitration of hydrocarbon compounds with dilute nitric acid. Also provided are processes for preparing industrially useful downstream derivatives of the nitrated compounds, as well as novel nitrated compounds and derivatives, and methods of using the derivatives in various applications. | 2011-02-03 |
| 20110028733 | PROCESS FOR THE PREPARATION OF 5-(2-ETHYL-DIHYDRO-1H-INDEN-2-YL)-1H-IMIDAZOLE AND SALTS THEREOF - The invention provides an improved, highly efficient method for preparing 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole, and its salts, in particular its pharmaceutically acceptable salts. | 2011-02-03 |
| 20110028734 | PROCESSES FOR PRODUCING N-ALKYLPYRAZOLE - Processes are provided for combining nonsubstituted hydrazine (N2H4), a strong acid, alcohol, and tetraalkoxypropane to produce N-alkylpyrazole. | 2011-02-03 |
| 20110028735 | Process for the Regioselective Preparation of 1-Alkyl-3-haloalkylpyrazole-4-carboxylic Acid Derivatives - The present invention relates to a process for the regioselective synthesis of 1-alkyl-3-halo-alkylpyrazole-4-carboxylic acid derivatives by cyclization of 2,3-disubstituted acrylic acid derivatives with hydrazines in the presence of carbonyl compounds. | 2011-02-03 |
| 20110028736 | Zofenopril Calcium - The present invention relates to zofenopril calcium form A substantially free of other forms of zofenopril calcium and to zofenopril calcium having a chemical purity of more than 98.5%. The present invention also relates to methods of preparing such zofenopril calcium. It further relates to compositions comprising such zofenopril calcium. Zofenopril calcium, (4S)-1-[(2S)-3-benzoylthio-2-methylpropionyl]-4-(phenylthio)-L-proline calcium salt, has the following structure: | 2011-02-03 |
| 20110028737 | METHOD FOR CONTINUOUSLY PRODUCING OXIDIZED CYCLIC PHENOL SULFIDES - The present invention discloses a method for continuously producing an oxidized cyclic phenol sulfide which comprises the continuous steps of reacting a para-alkyl phenol compound as a raw material with 1.7 to 2.5 molar equivalent of sulfur and 0.25 to 0.75 molar equivalent of an alkali metal reagent per 1 mol of the phenol compound (the first step); and oxidizing a cyclic phenol sulfide of the formula (2) produced by the above reaction with an oxidizing agent(s) in the same reactor as that of the first step and without taking the cyclic phenol sulfide out of the reactor; | 2011-02-03 |
| 20110028738 | PHOTODISSOCIABLE PROTECTIVE GROUP - The present invention provides a photolabile protecting group that can be removed by light irradiation under mild conditions. More specifically, the present invention provides a method comprising protecting a reactive functional group (e.g., a hydroxyl group, amino group, carboxyl group, carbonyl group, phosphodiester group, etc.) by the photolabile protecting group, and then removing the photolabile protecting group simply by light irradiation under neutral conditions. | 2011-02-03 |
| 20110028739 | TRI-SUBSTITUTED AROMATIC COMPOUND - A compound represented by the following formula (1): | 2011-02-03 |
| 20110028740 | METHOD FOR STARTING A GAS PHASE OXIDATION REACTOR THAT CONTAINS A CATALYTICALLY ACTIVE SILVER-VANADIUM OXIDE BRONZE - What is described is a method for starting a gas phase oxidation reactor that contains a bed of a first catalyst whose active material comprises a catalytically active silver-vanadium oxide bronze, and at least one bed of a second catalyst whose catalytically active material comprises vanadium pentoxide and titanium dioxide, and whose temperature is controllable by means of a heat transfer medium. In the operating state, a gas stream which comprises a loading c | 2011-02-03 |
| 20110028741 | Novel Platensimycin Derivatives, Their Intermediates, and Process for Preparing the Same, and New Process for Preparing Platensimycin - The present invention relates to novel platensimycin derivatives, their intermediates and preparing methods of the same. Platensimycin is known as an effective antibiotic material having a broad antimicrobial spectrum and its derivatives are also expected to be effective antibiotic candidates. The present invention also relates to a novel preparing method of platensimycin. The intermediates used for the production of platensimycin and its derivatives of the present invention are tricyclo ketone derivatives and tetracyclo derivatives. Tetracyclo derivatives are prepared from tricyclo ketone derivatives prepared by carbonyl ylide [3+2] cycloaddition of dia-zoketone derivative. | 2011-02-03 |
| 20110028742 | SULFUR-CONTAINING PROANTHOCYANIDIN OLIGOMER COMPOSITION AND PRODUCTION METHOD THEREOF - Provided are: method of producing a sulfur-containing proanthocyanidin oligomer by reducing the molecular weight of proanthocyanidin in plants so that they can be readily absorbed through the intestine of an organism; and a health food composition and a pharmaceutical composition which contain the resultant sulfur-containing proanthocyanidin oligomer as an active ingredient and which are useful for treating and preventing various lifestyle-related diseases and brain diseases caused by generation of active oxygen species as well as for preventing aging. | 2011-02-03 |
| 20110028743 | POLYCYCLIC ESTER CONTAINING CYANO GROUP AND LACTONE SKELETON - A polycyclic ester containing a cyano group and a lactone skeleton, represented by following Formula (1): | 2011-02-03 |
| 20110028744 | PROCESS FOR MANUFACTURING LIQUID EPOXY RESINS - A process for the production of liquid epoxy resins, including: contacting a polyhydric phenol and an epihalohydrin in the presence of an ionic catalyst to form a halohydrin intermediate reaction product; concurrently: reacting a portion of the halohydrin intermediate reaction product with an alkali hydroxide to form a solid salt suspended in a liquid mixture including a dehydrohalogenated product and unreacted halohydrin intermediate, wherein the alkali hydroxide is used at less than a stoichiometric amount; and removing water and epihalohydrin as a vapor from the reacting mixture; separating the solid salt from the liquid mixture; reacting at least a portion of the unreacted halohydrin intermediate with an alkali hydroxide in the presence of water to form an organic mixture including an epoxy resin and unreacted epihalohydrin and an aqueous solution including a salt; separating the aqueous mixture from the organic mixture; and separating the unreacted epihalohydrin from the liquid epoxy resin. | 2011-02-03 |
| 20110028745 | PROCESS FOR THE PREPARATION OF ALKYLENE OXIDE - A process for the preparation of alkylene oxide, which process involves mixing fresh feed containing organic hydroperoxide and alkene with a recycle stream to obtain a reaction mixture containing of from 5 to 80% wt of alcohol, based on total amount of reaction mixture, | 2011-02-03 |
| 20110028746 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS - The present invention relates to a process for preparing aldehydes by reacting an α,β-unsaturated carboxylic acid or a salt thereof with carbon monoxide and hydrogen in the presence of a catalyst comprising at least one complex of a metal of transition group VIII of the Periodic Table of the Elements with at least one compound of the formula (I), | 2011-02-03 |
| 20110028747 | METHOD FOR PREPARING FATTY ACID ALKYL ESTER USING FATTY ACID - A method for preparing fatty acid alkyl ester for bio-diesels is disclosed, wherein fatty acid, specifically fatty acid distillate reacts with alcohol in the presence of metal catalyst instead of conventional acid or solid acid catalyst. The method does not require the glycerin purification process, and has the superior conversion ratio of fatty acid. The method for preparing fatty acid alkyl ester comprises the step of carrying out an esterification reaction of fatty acid raw material with alcohol in the presence of metal catalyst. Preferably, the esterification reaction is carried out at the temperature of 200 to 350° C. and the pressure of atmospheric pressure to 10 bar, and the metal catalyst is a compound containing metal selected from the group consisting of cobalt, iron, manganese, zinc, titanium and mixture thereof. | 2011-02-03 |
| 20110028748 | NOVEL HYBRID ORGANIC-INORGANIC MATERIAL IM-19 AND METHOD OF PREPARING SAME - The invention relates to a novel hybrid organic-inorganic material containing an inorganic network of metal centres based on the element gallium, connected to each other by organic bridges, to the preparation and to the use thereof. The invention also relates to an intermediate solid obtained during the synthesis of said hybrid organic-inorganic material. | 2011-02-03 |
| 20110028749 | RUTHENIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE AMINOALCOHOL COMPOUND - A novel ruthenium compound that is useful as an asymmetric reduction catalyst for carbonyl compounds. The ruthenium compound of the present invention is represented by a formula (I): (Ru(X) | 2011-02-03 |
| 20110028750 | PROCESS FOR THE PREPARATION OF BETA-SANTALOL AND DERIVATIVES THEREOF - The present invention concerns a process for the preparation of a compound of formula (I) wherein R represents a Me or Et group, as well said compound in the form of any one of its stereoisomers or mixture thereof. The invention concerns also the use of compound (I) for the synthesis of β-santalol or of derivatives thereof. | 2011-02-03 |
| 20110028751 | PERFLUORO SULFONYL HALIDES AND RELATED SPECIES AS POLYMER SUPPORT MODIFIERS - Activated Supports, support-bound activators, strongly acidic supports, and silylating supports are provided; the activated support having the formula: | 2011-02-03 |
| 20110028752 | NOVEL BIS(FORMYLPHENYL) COMPOUND AND NOVEL POLYNUCLEAR POLYPHENOL COMPOUND DERIVED FROM THE SAME - A bis(formylphenyl) compound expressed by general formula (1) is manufactured by, for example, using a corresponding bis(hydroxy-formylphenyl) compound as the direct material and causing it to react with a halogenated alkoxycarbonyl hydrocarbon in the presence of a base according to a known phenylether manufacturing method. | 2011-02-03 |
| 20110028753 | Stabilized Compounds Having Secondary Structure Motifs - The present invention provides novel stabilized crosslinked compounds having secondary structure motifs, libraries of these novel compounds, and methods for the synthesis of these compounds libraries thereof. The synthesis of these novel stabilized compounds involves (1) synthesizing a peptide from a selected number of natural or non-natural amino acids, wherein said peptide comprises at least two moieties capable of undergoing reaction to promote carbon-carbon bond formation; and (2) contacting said peptide with a reagent to generate at least one crosslinker and to effect stabilization of a secondary structure motif. The present invention, in a preferred embodiment, provides stabilized p53 donor helical peptides. Additionally, the present invention provides methods for disrupting the p53/MDM2 binding interaction comprising (1) providing a crosslinked stabilized α-helical structure; and (2) contacting said crosslinked stabilized α-helical structure with MDM2. | 2011-02-03 |
| 20110028754 | PROCESS FOR HETEROGENEOUSLY CATALYZED ESTERIFICATION OF (METH)ACRYLIC ACID WITH OXYALKYLATED POLYOLS - The present invention relates to a process for heterogeneously catalyzed partial esterification of (meth)acrylic acid with oxyalkylated polyols, wherein the oxyalkylated polyols have at least 3 free hydroxyl groups, and wherein the catalyst is selected from the group comprising acidic ion exchange resins and/or acidic zeolites. The invention further relates to (meth)acrylic esters and urethane acrylates, obtained by a process according to the present invention, and to the use thereof as radiation-curable compounds. | 2011-02-03 |
| 20110028755 | LOW CHLORINE, MULTI-STAGED METHOD FOR PRODUCING CYCLOALIPHATIC DISOCYANATES - Low chlorine, multi-staged method for producing cycloaliphatic diisocyanates. The invention relates to a multi-staged method for the continuous low-chlorine production of cycloaliphatic diisocyanates, comprising the synthesis of diaminodipheynl alkanes, the hydration thereof into the corresponding cycloaliphatic diamines and the subsequent conversion of cycloaliphatic diamines to the corresponding cycloalkylene biscarbamates and the thermal cleaving of the latter into the cycloaliphatic diisocyanates and alcohol. | 2011-02-03 |
| 20110028756 | USE OF AMIDOXIME CARBOXYLIC ACID ESTERS AND N-HYDROXYGUANIDINE CARBOXYLIC ACID ESTERS FOR PRODUCING PRODRUGS - The invention relates to a method for improving the bioavailability of pharmaceutical substances and for allowing the pharmaceutical substances to permeate the blood-brain barrier, the pharmaceutical substances having at least one or more amidine, guanidine, N-hydroxyamidine (amidoxime) or N-hydroxyguanidine functions. The invention also relates to medicaments containing the correspondingly modified pharmaceutical substances. | 2011-02-03 |
| 20110028757 | MANUFACTURING METHOD OF 2-HYDROXY-5-PHENYLALKYLAMINOBENZOIC ACID DERIVATIVES AND THEIR SALTS - The present invention provides an efficient method for mass-producing 2-hydroxy-5-(substituted)phenylalkylaminobenzoic acid derivative represented by the specific Chemical formula or its salt, particularly 2-hydroxy-5-[2-(4-trifluoromethylphenyl)ethylamino] benzoic acid or its salt. | 2011-02-03 |
| 20110028758 | Trans-cinnamic acid derivative, its preparation mathod and the use - A compound of formula (I) or its pharmaceutically acceptable salt is prepared by ring opening of osthol under basic condition. The compound of formula (I) or its pharmaceutically acceptable salt has activity of selectively inhibiting tumor cells and lower toxicity, and can be used for preparing anti-tumor drugs. | 2011-02-03 |
| 20110028759 | Process for the Purification of Organic Acids - A process for recovery and purification of an organic acid from a fermentation broth containing a salt form of the organic acid, comprises the steps of subjecting the fermentation broth to one of ultrafiltration and microfiltration to form a first permeate, concentrating the first permeate to form a concentrated broth, subjecting the concentrated broth to a supported liquid membrane for extraction of lactic acid into a separate stream comprising an extracted solution, subjecting the extracted solution to activated carbon for colour removal, a cation exchange resin for demineralization, and an anion exchange resin for removal of anionic impurities to form a post polished organic acid, filtering the post polished organic acid to remove impurities above a predetermined threshold and concentrating the post polished organic acid to a desired concentration. | 2011-02-03 |
| 20110028760 | METHOD FOR THE REACTIVE VAPORIZATION OF GLYCEROL - The subject of the present invention is a method for the reactive vaporization of aqueous solutions of glycerol in a fluidized bed containing a reactive solid. The method of the invention makes it possible to simultaneously vaporize an aqueous solution of glycerol, to remove the impurities that are present in this solution or that are generated during the evaporation, and to carry out the dehydration reaction of the glycerol to acrolein and/or the oxydehydration reaction of the glycerol to acrylic acid. | 2011-02-03 |
| 20110028761 | PROCESS FOR THE PREPARATION OF TRIAMIDES FROM AMMONIA AND AMIDODICHLORIDES - The invention relates to a process for the preparation of triamides from ammonia and amido-dichlorides. | 2011-02-03 |
| 20110028762 | Process for Producing Cyclohexylbenzene - In a process for producing cyclohexylbenzene, benzene and hydrogen are fed to at least one reaction zone. The benzene and hydrogen are then contacted in the at least one reaction zone under hydroalkylation conditions with a catalyst system comprising a molecular sieve having an X-ray diffraction pattern including d-spacing maxima at 12.4±0.25, 6.9±0.15, 3.57±0.07 and 3.42±0.07 Angstrom, and at least one hydrogenation metal to produce an effluent containing cyclohexylbenzene. The catalyst system has an acid-to-metal molar ratio of from about 75 to about 750. | 2011-02-03 |
| 20110028763 | CYCLOHEXANONE PRODUCTION PROCESS WITH IMPURITIES REMOVAL - The present invention relates to a method for preparing cyclohexanone from phenol in a first process, the first process being a cyclohexanone production process comprising hydrogenating phenol to form a product stream comprising cyclohexanone, phenol and side-products (RSP), including cyclohexanol and undesirable side-product; separating at least part of the product stream having a lower boiling point than cyclohexanone have been removed, into a first fraction comprising cyclohexanone and a second fraction comprising phenol, cyclohexanol and RSP, using distillation; and separating the second fraction into a third fraction, rich in cyclohexanol and comprising RSP, and a fourth fraction, rich in phenol and comprising RSP, using distillation. The invention further relates to an installation for carrying out a method of the invention. | 2011-02-03 |
| 20110028764 | PROCESS FOR THE SELECTIVE PREPARATION OF ACETALDEHYDE FROM ACROLEIN AND ONE OR MORE AMMONIUM SALTS DISSOLVED IN WATER - The present invention relates to a process for the selective preparation of acetaldehyde, characterized in that acrolein and one or more ammonium salts dissolved in water are reacted continuously under high pressures and at temperatures of 300-400° C. | 2011-02-03 |
| 20110028765 | PROCESS AND APPARATUS FOR EFFICIENT RECOVERY OF DICHLOROHYDRINS - A process and apparatus is disclosed for recovering dichlorohydrins from a hydrochlorination reactor effluent stream comprising dichlorohydrins, one or more compounds selected from esters of dichlorohydrins, monochlorohydrins and/or esters thereof, and multihydroxylated-aliphatic hydrocarbon compounds and/or esters thereof, and optionally one or more substances comprising water, chlorinating agents, catalysts and/or esters of catalysts. The reactor effluent stream is distilled to produce a dichlorohydrin-rich vapor phase effluent stream. The dichlorohydrin-rich vapor phase effluent stream is cooled and condensed in two unit operations conducted at two different temperatures and a portion of the liquid phase effluent stream produced by the first unit operation is recycled to the distillation step for reflux. Product streams produced by the process and apparatus are suitable for further processing in a further unit operation, such as dehydrochlorination. Advantages include recovery of high purity dichlorohydrins, more efficient recovery of dichlorohydrins, and reduced capital investment in the recovery equipment. | 2011-02-03 |
| 20110028766 | CONVERSION OF A MULTIHYDROXYLATED-ALIPHATIC HYDROCARBON OR ESTER THEREOF TO A CHLOROHYDRIN - The present invention relates to a process for converting at least one multihydroxylated-aliphatic hydrocarbon and/or an ester thereof to at least one chlorohydrin and/or an ester thereof, comprising at least one reaction step in which the multihydroxylated-aliphatic hydrocarbon and/or ester thereof is contacted with hydrogen chloride under reaction conditions to produce the chlorohydrin and/or ester thereof, followed by at least one downstream processing step in which the effluents of the reaction step are processed, wherein the downstream processing step is performed in such conditions that the effluents containing the chlorohydrin and/or ester thereof are kept at a temperature of less than 120° C. The invention allows to minimize the liberation of hydrogen chloride from the products of the hydrochlorination reaction, hence reducing the corrosion of the downstream equipment and reducing the need to use costly corrosion resistant materials. | 2011-02-03 |
| 20110028767 | METHOD FOR PURIFYING FERMENTATION ALCOHOL - The present invention relates to a method for purifying an aqueous solution of fermentation alcohol to give anhydrous alcohol, wherein a mash column is controlled such a manner that an alcohol concentration of an alcohol/water mixed vapor distilled from a mash column is less than 50% by weight and a reflux amount of a condensate to a distillation column is controlled such a manner that an alcohol concentration of an alcohol/water mixed vapor that is distilled from the distillation column is 55 to 85% by weight. According to the present method, the purification for obtaining an anhydrous alcohol from an aqueous solution of a fermentation alcohol with the use of a mash column, a pressurized distillation column and a membrane separator can be more conveniently carried out with an extremely high energy efficiency as the whole process. | 2011-02-03 |
| 20110028768 | PROCESS FOR PRODUCING FLUOROALKYL IODIDE TELOMER - A novel process for producing a fluoroalkyl iodide telomer is provided, which is able to obtain a fluoroalkyl iodide telomer having a desired chain length, efficiently. | 2011-02-03 |
| 20110028769 | PROCESS FOR MAKING 1,1,1,4,4,4-HEXAFLUORO-2-BUTENE - A process is disclosed for making 1,1,1,4,4,4-hexafluoro-2-butene. The process involves reacting 2,2-dichloro-1,1,1-trifluoroethane with copper in the presence of an amide solvent and 2,2′-bipyridine. A process is also disclosed for making 1,1,1,4,4,4-hexafluoro-2-butene. The process involves reacting 2,2-dichloro-1,1,1-trifluoroethane with copper in the presence of an amide solvent and a Cu(I) salt. A process is further disclosed for making 1,1,1,4,4,4-hexafluoro-2-butene. The process involves reacting 2,2-dichloro-1,1,1-trifluoroethane with copper in the presence of an amide solvent, 2,2′-bipyridine and a Cu(I) salt. | 2011-02-03 |
| 20110028770 | HYDROGENATION CATALYST - An alpha-alumina support for a hydrogenation catalyst useful in hydrogenating fluoroolefins is provided. | 2011-02-03 |
| 20110028771 | Aromatics Co-Production in a Methanol-to-Propylene Unit - The present invention provides a reactor system having: (1) a first reactor receiving an oxygenate component and a hydrocarbon component and capable of converting the oxygenate component into a light olefin and the hydrocarbon component into alkyl aromatic compounds; (2) a separator system for providing a first product stream containing a C | 2011-02-03 |
| 20110028772 | Catalyst Composition, The Method of Manufacturing, and the Process of Use Thereof in Aromatics Alkylation - A catalyst composition comprises a crystalline MCM-22 family molecular sieve and a binder, wherein the catalyst composition is characterized by an extra-molecular sieve porosity greater than or equal to 0.122 ml/g for pores having a pore diameter ranging from about 2 nm to about 8 nm, wherein the porosity is measured by N | 2011-02-03 |
| 20110028773 | Deoxygenation of Bio-Oils and Other Compounds to Hydrocarbons in Supercritical Media - A process for the complete deoxygenation of an oxygenate, especially those from bio-oils comprises forming a reaction mixture comprising the oxygenate, molecular hydrogen, and a hydrodeoxygenation catalyst in a solvent. The reaction mixture is maintained at a temperature that is 0.7 to 1.3 times the solvent critical temperature in absolute temperature units (K). Complete deoxygenation occurs via a hydrodeoxygenation pathway and a decarbonylation pathway. | 2011-02-03 |
| 20110028774 | Hypernucleophilic Catalysts For Detoxification Of Chemical Threat Agents - A polymeric hypernucleophilic catalyst is effective for hydrolytic destruction of chemical threat agents under mild conditions, e.g., near neutral pH and at ambient temperatures. The polymeric hypernucleophilic catalysts are particularly useful to affect rapid destruction of chemical threat agents on sensitive surfaces such as paint, metal, rubber, plastic, fabric, wood, and skin. Catalyst formulations such as creams, lotions, sprays, foams, powders, or gels, and articles such as filters, wipes, membranes, yarns, fabrics, and articles of clothing, may be used for detoxification of or prophylactic protection against chemical threat agents. | 2011-02-03 |
| 20110028775 | THERAPEUTIC INFUSION AND TRANSFER SYSTEM FOR USE WITH RADIOACTIVE AGENTS - Described herein are infusion systems and methods for delivering a radiopharmaceutical agent to a subject without exposing an administering health care professional to a potentially deleterious amount of radiation. | 2011-02-03 |
| 20110028776 | Packaged Magnetic Therapeutic Topical Preparation - A topical preparation externally applied to the skin, the preparation containing particles that can be magnetized. The preparation being stored in a container with a magnetic source. | 2011-02-03 |
| 20110028777 | FREQUENCY ALTERED FEEDBACK FOR TREATING NON-STUTTERING PATHOLOGIES - Methods and devices treat treating non-stuttering pathologies having impaired or decreased communication skills by administering a frequency altered auditory feedback signal to a subject having a non-stuttering pathology while the subject is speaking or talking to thereby improve the subject's communication skills. | 2011-02-03 |
| 20110028779 | TUBULAR IMPLANTABLE SLING AND RELATED DELIVERY SYSTEMS, METHODS AND DEVICES - The invention generally relates to surgically implantable supportive slings. More specifically, in various embodiments, the invention is directed to systems, devices and methods relating to a surgically implantable supportive sling having an adjustable shape. | 2011-02-03 |
| 20110028780 | Methods Of Producing Pluripotent Stem Cell-Generated Embryos, And Animals Derived Therefrom - Methods for generating embryos using pluripotent stem cells are provided. The subject methods include methods for generating chimeric embryos, wherein only a subset of the cells of each embryo are genetically identical to the pluripotent stem cells used in the generation process. The subject methods also include methods for generating embryos that are identical or are essentially genetic clones of the pluripotent stem cells (e.g., the resulting embryos are substantially identical, genetically, to the pluripotent stem cells used in the generation process). | 2011-02-03 |
| 20110028782 | Peroral transgastric endoscopic techniques - Methods and apparatus for accessing the peritoneal cavity and for ligation of fallopian tubes. A representative method includes using an endoscope to orally access a gastric wall. The gastric wall is punctured to provide access to a peritoneal cavity. The endoscope is advanced into the peritoneal cavity through the puncture. A fallopian tube is located and ligated. The endoscope is removed. | 2011-02-03 |
| 20110028783 | MULTI-LUMEN ENDOSCOPIC ACCESSORY AND SYSTEM - The embodiments of the present invention relate to an endoscopic system and accessories. In particular, the various embodiments relate to endoscopic systems in which an accessory comprises a multi-lumen device that is capable of quantitatively delivering at least a catheter, a balloon, and a needle to a site. The accessory is configured to allow for individual, independent control of its components. For example, in some embodiments, the needle and guidewire can be independently controlled. In addition, the needle may be retracted back into an inner lumen of the catheter body. Accordingly, during use, the accessory of the embodiments allows the user to maintain access to an incision site without having to exchange or remove accessories for various parts of the procedure | 2011-02-03 |
| 20110028784 | MULTI-LUMEN ENDOSCOPIC ACCESSORY AND SYSTEM - The embodiments of the present invention relate to an endoscopic system and accessories. In particular, the various embodiments relate to endoscopic systems in which an accessory comprises a multi-lumen device that is capable of quantitatively delivering at least a catheter, a balloon, and a needle to a site. The accessory is configured to allow for individual, independent control of its components. For example, in some embodiments, the needle and guidewire can be independently controlled. In addition, the needle may be retracted back into an inner lumen of the catheter body. Accordingly, during use, the accessory of the embodiments allows the user to maintain access to an incision site without having to exchange or remove accessories for various parts of the procedure | 2011-02-03 |
| 20110028785 | Endoscope with adjustable viewing angle - An endoscope with adjustable viewing angle has a viewing angle adjusting mechanism mounted on a handheld body and a control module mounted inside the handheld body. The viewing angle adjusting mechanism has a cable seat pivotally mounted on the handheld body, an adjustable knob mounted on the cable seat, a flexible tube, a hollow flexible cable joined with one end of a flexible tube, and two pull strings between the other end of the flexible tube and the adjusting knob. Given that, while the cable seat is rotated, the image acquisition module on one end of the flexible cable can be controlled to rotate synchronously. The relative pulling and releasing movement of the two pull strings driven by turning the adjusting knob makes the flexible tube bend correspondingly so as to further adjust the viewing angle of the image acquisition module. | 2011-02-03 |
| 20110028786 | CAPSULE-TYPE ENDOSCOPE - A capsule-type endoscope includes a capsule, an objective optical system, an image pickup element, and at least one illumination light source having a light-emitting surface, and a transparent cover. In several embodiments of the capsule-type endoscope according to the present invention, an inner surface of the transparent cover is spherical within a field of view of the objective optical system so as to have a center of curvature, the center of curvature is offset from the optical axis of the objective optical system, and a specified condition is satisfied so as to avoid flare in the objective optical system caused when light from the one (or more) illumination light source(s) enters the entrance pupil of the objective optical system. In another embodiment, the inner surface of the transparent cover has the shape of an ellipsoid. Observation methods using the capsule-type endoscope are also disclosed. | 2011-02-03 |
| 20110028787 | TREATMENT TOOL - Provided is a treatment tool including: an elongated member which is formed of a flexible material and includes first and second terminals; a first body portion which is fixed to the first terminal so as to function in a target; a handle portion which is provided in the second terminal and is provided with a rotating holding portion holding the elongated member so as to be rotatable about the axis of the elongated member; and a second body portion which is attached to the handle portion so as to function in a target and is rotated relative to the elongated member when rotating the handle member relative to the elongated member. The treatment tool is capable of performing a cleaning treatment or the like while curtailing extraneous matter from being scattered in the vicinity thereof and reducing contamination thereof. | 2011-02-03 |
| 20110028788 | Non-Contact Infrared Fiber-Optic Device for Monitoring Esophageal Temperature to Prevent Thermal Injury During Radiofrequency Catheter Ablation or Cryoablation - An infrared fiber-optic device is able to monitor esophageal temperature during an ablation/cryoablation procedure over a volume of interest to sense whether the temperature is too high or too low. The device may include a plurality of optical fibers each with a wide angle lens collectively disposed circumferentially and longitudinally to cover the volume of interest, as the particular region over which undesirable temperature may not be known beforehand. In other examples, the device may include an embedded array of infrared sensors extending sufficiently to encompass a volume of interest. The device may be used as part of a feedback control to regulate and stop operation of the ablation/cryoablation procedure to prevent vessel damage. | 2011-02-03 |
| 20110028789 | SURGICAL ACCESS APPARATUS AND METHODS - There is disclosed a method of gaining access to a lateral side of a spinal column for a spinal fusion procedure at a surgical site. In an embodiment, the method includes inserting a distal end of a shaft through skin at an entry point into a patient; steering the shaft toward a surgical site using a visualization device to avoid damage to structures between the entry point and the surgical site; and retracting tissue between the entry point and the surgical site to define a pathway for access to the lateral side of the spinal column for a spinal fusion procedure. Other embodiments are also disclosed. | 2011-02-03 |
| 20110028790 | DISPOSABLE ENDOSCOPIC ACCESS DEVICE AND PORTABLE DISPLAY - Various embodiments for providing removable, pluggable and disposable opto-electronic modules for illumination and imaging for endoscopy or borescopy are provided for use with portable display devices. Generally, various rigid, flexible or expandable single use medical or industrial devices with an access channel, can include one or more solid state or other compact electro-optic illuminating elements located thereon. Additionally, such opto-electronic modules may include illuminating optics, imaging optics, and/or image capture devices, and airtight means for suction and delivery within the device. The illuminating elements may have different wavelengths and can be time-synchronized with an image sensor to illuminate an object for 2D and 3D imaging, or for certain diagnostic purposes. | 2011-02-03 |
| 20110028791 | ARCUATE SURGICAL GUIDANCE SYSTEM AND METHODS - This disclosure is directed to minimally-invasive devices, methods and systems used through small access portals to minimize trauma to structures adjacent the treatment site. The access device includes a guide frame and a cannula support washer movebly coupled to the guide frame. The washer has a cannula port aperture extending therethrough and a surface geometry complementary to the surface geometry of the guide frame. The complementary surface geometries limit movement of the cannula port aperture to arcuate movement along a surface segment of a sphere. | 2011-02-03 |
| 20110028792 | TISSUE RETRACTORS WITH FLUID EVACUATION/INFUSION AND/OR LIGHT EMISSION CAPABILITY - Retractor apparatus including a blade and a fluid port and/or a light emitter associated with blade, and surgical systems including an arm and a retractor apparatus. | 2011-02-03 |
| 20110028793 | METHODS AND DEVICES FOR PROVIDING ACCESS INTO A BODY CAVITY - Methods and devices are provided for providing surgical access into a body cavity. In one embodiment, a surgical access device is provided that includes a housing having multiple access ports for receiving surgical instruments, and a retractor removably coupled to the housing and having a working channel configured to extend into a body cavity. With the housing and retractor mated together, a portion of the housing through which instruments can be inserted can rotate relative to the retractor. The retractor can be positioned in tissue using an inserter tool configured to seat the retractor and to automatically release the retractor into position within the tissue. The retractor can be removed from the tissue using a cord coupled to the retractor. | 2011-02-03 |
| 20110028794 | METHODS AND DEVICES FOR PROVIDING ACCESS INTO A BODY CAVITY - Methods and devices are provided for providing surgical access into a body cavity. In one embodiment, a surgical access device is provided that includes a housing having multiple access ports for receiving surgical instruments, and a retractor removably coupled to the housing and having a working channel configured to extend into a body cavity. With the housing and retractor mated together, a portion of the housing through which instruments can be inserted can rotate relative to the retractor. The retractor can be positioned in tissue using an inserter tool configured to seat the retractor and to automatically release the retractor into position within the tissue. The retractor can be removed from the tissue using a cord coupled to the retractor. | 2011-02-03 |
| 20110028795 | SURGICAL PORTAL DEVICE INCLUDING TEXTURED SURFACE - A surgical portal device having enhanced retention characteristics includes a body portion dimensioned for insertion within a tissue tract. The body portion includes an outer wall defining a longitudinal axis and having a proximal end, a distal end, and a lumen configured to allow a surgical instrument to pass therethrough. A thread segment extends at least partially along the outer wall of the body portion. At least one of the outer wall and the thread segment has a textured surface. The textured surface may define irregularities. The irregularities are dimensioned to engage or receive tissue segments adjacent the tissue tract to thereby facilitate retention of the body portion relative thereto. | 2011-02-03 |
| 20110028796 | Cannula Anchor - Cannula anchor assemblies are disclosed which consist of a threaded cannula and a cannula anchor. The cannula anchor system allows for secure anchoring into the body wall, and proper cannula height adjustment prior to and during surgery. Sutures through the body wall may be secured to the cannula anchor either directly through the cannula anchor, or around suture posts attached therein. The cannula anchor also prevents excessive plunge of a trocar into the patient. The cannula anchor is generally configured with internal threads that mate with a threaded cannula. | 2011-02-03 |
| 20110028797 | INTRACARDIAC SHEATH STABILIZER - A surgical stabilizer for use with a surgical site retractor has a base, a bendable arm, and a distal cuff adapted to resiliently hold a tube of an elongated port-access device. The cuff may have a body defining a partial enclosure within which is held a highly flexible gasket having a slit for resiliently receiving the tube. The surgical site retractor may have a collapsible ring and a flexible outer portion attached thereto, the ring being sized to pass through an intercostal incision and expand therein under adjacent ribs to prevent removal, and the flexible outer portion extending out of the incision and drawing over the stabilizer base to mutually secure the retractor and base. The port-access tube may be for a heart valve delivery system using an elongated port-access device for transapically delivering a prosthetic heart valve to the aortic valve annulus. A method involves partly installing the surgical site retractor, anchoring the base of the stabilizer with the flexible outer portion, deploying the port-access tube from outside the body through the incision and through a puncture in the heart wall, and resiliently capturing a tube of the port-access within the partial enclosure of the stabilizer cuff. A second bendable arm on the base having a clip may be used to hold still a proximal end of the port-access device. | 2011-02-03 |
| 20110028798 | Electronically initiating an administration of a neuromodulation treatment regimen chosen in response to contactlessly acquired information - Described embodiments include a system, and a method. A described method includes acquiring electronic data indicative of a property of a mammal without making physical contact with the mammal. The method also includes extracting digital information indicative of a physiological characteristic of the mammal from the electronic data indicative of the property of the mammal. The method further includes choosing from an electronically accessible treatment database a neuromodulation treatment regimen for administration to the mammal in response to the information indicative of a physiological characteristic of the mammal. The method also includes electronically initiating an administration of the chosen neuromodulation treatment regimen to a nervous system component of the mammal. | 2011-02-03 |
| 20110028799 | Broadcasting a signal indicative of a disease, disorder, or symptom determined in response to contactlessly acquired information - Described embodiments include a system, and a method. A described system includes a sensor device operable to detect a property of a mammal without a direct physical contact with the mammal. The system also includes a patient assessment device operable to evaluate the detected property of the mammal for an indicator of a disease. The system further includes a patient information device including a computer-readable medium, and configured to maintain and to provide access to information corresponding to the indication of the disease. The system further includes a transmitter device operable to broadcast a signal indicative of the disease. | 2011-02-03 |
| 20110028800 | COMPACT MOTION-SIMULATING DEVICE - A reaction-testing system is provided to simulate motion to an individual. Generally, the reaction-testing system includes a motion-simulating device, a reflective device, a control unit, and an input device that is activated by an individual In exemplary embodiments, the motion-simulating device includes a beam that accommodates a first and second plurality of light sources capable of, at least, alternating between an active and idle condition. These light sources are arranged amongst occlusion features in a mounting pattern such that light emitted from the first plurality is directly viewable by an individual and light emitted from the second plurality is indirectly viewed by the individual through the reflecting surface. The control unit is configured to sequentially activate the light sources sequentially to generate pulses of light on that, when perceived by the individual, appear as a light moving along a vector. | 2011-02-03 |
| 20110028801 | CARDIOVASCULAR VESSEL ELASTICITY MONITORING - Elasticity of a cardiovascular vessel of a patient is monitored to provide an indication of whether the patient's health is changing. In some aspects the elasticity of a cardiovascular vessel is determined irrespective of the current blood pressure level of the patient at the time the elasticity is determined. For example, vessel elasticity may be determined based on a defined set of data that maps vessel elasticity with reflectance times for different blood pressure levels. In some implementations, this set of data corresponds to a set of iso-pressure lines. | 2011-02-03 |
| 20110028802 | METHODS AND APPARATUS FOR PRODUCING AND USING LIGHTLY FILTERED PHOTOPLETHYSMOGRAPH SIGNALS - One or more physiological conditions of a patient can be observed by obtaining a photoplethysmograph (“PPG”) signal from the patient and by only lightly filtering that signal. The light filtering of the PPG may be such as to only remove (for example) high frequency noise from that signal, while leaving in the signal most or all frequency components that are due to physiological events in the patient. In this way, such physiological events can be observed via a visual display of the lightly filtered PPG signal and/or via other signal processing of the lightly filtered PPG signal to automatically extract certain physiological parameters or characteristics from that signal. | 2011-02-03 |
| 20110028803 | METHOD AND DEVICE FOR NON-INVASIVE DETERMINATION OF THE CONCENTRATION OF A SUBSTANCE IN A BODY FLUID - The present invention relates generally to the field of measuring glucose levels in a body fluid of a subject, in particular to non-invasive measuring of blood glucose in blood of a subject. A device is disclosed comprising an electrically conducting probe comprising a plurality of electrodes adapted for measuring electrical impedance of the tissue of a subject, typically skin, a sensing device adapted for sensing at least one concentration of an ion in the tissue, typically acidity (pH), wherein said electrically conducting probe and said sensing device are adapted to obtain said electrical impedance of the tissue and said concentration of an ion in the tissue simultaneously. The device further comprises a blood glucose determining unit adapted for determining an estimate, typically a concentration, of blood glucose based on said electrical impedance of the tissue and said concentration of an ion in the tissue. Further, a device is disclosed comprising an electrically conducting probe comprising a plurality of electrodes adapted for measuring electrical impedance of the tissue of a subject, typically the skin, wherein at least one of said plurality of electrodes is adapted to, when being in voltage mode, sense a signal representative of a concentration of an ion in the tissue, typically acidity (pH), wherein said electrically conducting probe is adapted to simultaneously obtain said impedance of the tissue and said concentration of an ion in the tissue, the device also comprising a blood glucose determining unit adapted for determining an estimate, typically a concentration, of blood glucose based on said electrical impedance of the tissue and said concentration of an ion in the tissue. Furthermore, methods for non-invasive determination of an estimate of blood glucose in blood of a subject are disclosed. | 2011-02-03 |
| 20110028804 | Use of Heat Sensitive Color Changing Formula to Detect and Prevent the Onset of Decubitus Ulcers - A method for diagnosing the onset of necrosis, decubiti, and/or decubitus ulcers in the skin of a patient. Included is a topical product accessed in liquid form and applied to the skin. The product displays thermochromic temperature change when the product comes into contact with human skin tissue to identify body parts at risk for tissue necrosis by the color differences. | 2011-02-03 |
| 20110028805 | INFORMATION PROCESSING APPARATUS, METHOD, AND PROGRAM - An information processing apparatus includes: reproduction means for reproducing 3D content; and detection means for detecting a biological signal associated with a viewer who is viewing the 3D content, wherein the reproduction means attenuates the 3D effect of the 3D content when the viewer's biological signal produced when the 3D content is being reproduced exceeds a threshold value. | 2011-02-03 |
| 20110028806 | REFLECTANCE CALIBRATION OF FLUORESCENCE-BASED GLUCOSE MEASUREMENTS - A noninvasive or minimally invasive procedure and system for measuring blood glucose levels is disclosed. A set of photodiodes detects the fluorescence and reflectance of light energy emitted from one or more emitters, such as LEDs, into a patient's skin. In an embodiment, small molecule metabolite reporters (SMMRs) that bind to glucose are introduced to the measurement area to provide more easily detected fluorescence. | 2011-02-03 |
| 20110028807 | Contact lens for collecting tears and detecting at least one analyte - Utilization of a contact device placed on the eye in order to detect physical and chemical parameters of the body as well as the non-invasive delivery of compounds according to these physical and chemical parameters, with signals being transmitted continuously as electromagnetic waves, radio waves, infrared and the like. One of the parameters to be detected includes non-invasive blood analysis utilizing chemical changes and chemical products that are found in the conjunctiva and in the tear film. A transensor mounted in the contact device laying on the cornea or the surface of the eye is capable of evaluating and measuring physical and chemical parameters in the eye including non-invasive blood analysis. The system utilizes eye lid motion and/or closure of the eye lid to activate a microminiature radio frequency sensitive transensor mounted in the contact device. The signal can be communicated by wires or radio telemetered to an externally placed receiver. The signal can then be processed, analyzed and stored. Several parameters can be detected including a complete non-invasive analysis of blood components, measurement of systemic and ocular blood flow, measurement of heart rate and respiratory rate, tracking operations, detection of ovulation, detection of radiation and drug effects, diagnosis of ocular and systemic disorders and the like. | 2011-02-03 |
| 20110028808 | METHOD AND APPARATUS FOR EXAMINATION OF CANCER, SYSTEMIC LUPUS ERYTHEMATOSUS (SLE), OR ANTIPHOSPHOLIPID ANTIBODY SYNDROME USING NEAR-INFRARED LIGHT - An object of the present invention is to provide apparatuses for examining/diagnosing clinical disease of cancer, systemic lupus erythematosus (SLE), or antiphospholipid antibody syndrome. Blood, blood-derived component, urine, sweat, nail, skin, or hair is irradiated with light having a wavelength of 400 to 2,500 nm or a part of the range, of which the reflection light, the transmission light, or the transmission reflection light is then detected to give spectroscopic absorbance data, and afterward a previously prepared analysis model is used to analyze the absorbance over the whole wavelengths or at a specific wavelength for the measurement to allow the achievement of the object. | 2011-02-03 |
| 20110028809 | PATIENT MONITOR AMBIENT DISPLAY DEVICE - Embodiments of the disclosure include an orb or lamp communicating with a noninvasive monitor to provide a readily identifiable point indication of a wellness of a monitored patient. In an embodiment the orb emits a color gradient from a first color through at least two other colors responsive to values of a wellness measurement. Exemplary wellness indications include one or a statistical combination of blood constituent measurements, combinations of other physiological parameters, or the like. | 2011-02-03 |
| 20110028810 | Systems And Methods For Resolving The Continuous Wavelet Transform Of A Signal - According to an embodiment, techniques for estimating scalogram energy values in a wedge region of a scalogram are disclosed. A pulse oximetry system including a sensor or probe may be used to receive a photoplethysmograph (PPG) signal from a patient or subject. A scalogram, corresponding to the obtained PPG signal, may be determined. In an approach, energy values in the wedge region of the scalogram may be estimated by performing convolution-based or convolution-like operations on the obtained PPG signal, or a transformed version thereof, and the scalogram may be updated according to the estimated values. In an approach, a deskewing technique may be used to align data prior to adding the data to the scalogram. In an approach, one or more signal parameters may be determined based on the resolved and estimated values of the scalogram. | 2011-02-03 |
| 20110028811 | NON-INVASIVE PHYSIOLOGICAL SENSOR COVER - A sensor cover according to embodiments of the disclosure is capable of being used with a non-invasive physiological sensor, such as a pulse oximetry sensor. Certain embodiments of the sensor cover reduce or eliminate false readings from the sensor when the sensor is not in use, for example, by blocking a light detecting component of a pulse oximeter sensor when the pulse oximeter sensor is active but not in use. Further, embodiments of the sensor cover can prevent damage to the sensor. Additionally, embodiments of the sensor cover prevent contamination of the sensor. | 2011-02-03 |
| 20110028812 | METHOD FOR SPECTROPHOTOMETRIC BLOOD OXYGENATION MONITORING - A method and apparatus for non-invasively determining a blood oxygenation level within a subject's tissue is provided. The method includes the steps of: a) providing a spectrophotometric sensor operable to transmit light into the subject's tissue, and to sense the light; b) inputting into the sensor at least one of the subject's age, weight, brain development, and head size; c) spectrophotometrically sensing the subject's tissue along a plurality of wavelengths using the sensor, and producing signal data from sensing the subject's tissue; and d) processing the signal data utilizing the at least one of the subject's age, weight, brain development, and head size, to determine the blood oxygen saturation level within the subject's tissue using a difference in attenuation between the wavelengths. | 2011-02-03 |
| 20110028813 | Systems And Methods For Estimating Values Of A Continuous Wavelet Transform - According to embodiments, techniques for estimating scalogram energy values in a wedge region of a scalogram are disclosed. A pulse oximetry system including a sensor or probe may be used to receive a photoplethysmograph (PPG) signal from a patient or subject. A scalogram, corresponding to the obtained PPG signal, may be determined. In an arrangement, energy values in the wedge region of the scalogram may be estimated by calculating a set of estimation locations in the wedge region and estimating scalogram energy values at each location. In an arrangement, scalogram energy values may be estimated based on an estimation scheme and by combining scalogram values in a vicinity region. In an arrangement, the vicinity region may include energy values in a resolved region of the scalogram and previously estimated energy values in the wedge region of the scalogram. In an arrangement, one or more signal parameters may be determined based on the resolved and estimated values of the scalogram. | 2011-02-03 |
| 20110028814 | Medical Monitoring Patch Device And Methods - Embodiments described herein may include systems and methods for monitoring physiological parameters of a patient. Specifically, embodiments disclose the use of a generally self-contained pulse oximeter that is small and lightweight, such that it may be comfortably affixed to a patient to provide physiological data pertaining to the patient. Embodiments also provide methods of using and manufacturing a pulse oximetry patch. | 2011-02-03 |
| 20110028815 | ANALYTE SENSORS AND METHODS OF MANUFACTURING SAME - Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system | 2011-02-03 |
| 20110028816 | ANALYTE SENSORS AND METHODS OF MANUFACTURING SAME - Analyte sensors and methods of manufacturing same are provided, including analyte sensors comprising multi-axis flexibility. For example, a multi-electrode sensor system | 2011-02-03 |
| 20110028817 | Continuous Glucose Monitoring System and Methods of Use - A continuous glucose monitoring system including a sensor configured to detect one or more glucose levels, a transmitter operatively coupled to the sensor, the transmitter configured to receive the detected one or more glucose levels, the transmitter further configured to transmit signals corresponding to the detected one or more glucose levels, and a receiver operatively coupled to the transmitter configured to receive transmitted signals corresponding to the detected one or more glucose levels, and methods thereof, are disclosed. In one aspect, the transmitter may be configured to transmit a current data point and at least one previous data point, the current data point and the at least one previous data point corresponding to the detected one or more glucose levels. | 2011-02-03 |
